Ventricular Arrhythmias with L-Dopa and Amantadine Hydrochloride Therapy during Halothane Anaesthesia

Breese R. , and Prange A. (1971): “Chronic Dopa Treatment: Effects on the Concentration of Norepinephrine in the Hearts and Brains of Rats”, European Journal of Pharmacology, 13, 259–261.

Goldberg L. I. (1971): “Levodopa and Anesthesia”, Anesthesiology, 34, 1–3.

Grelak R. D. , Clark R. , Stump J. M. , and Vernier V. G. (1970): “Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism”, Science, 169, 203–204.

Hunter K. R. , Laurence D. R. , Hollman A. , and Stern D. M. (1971): “Levodopa in Parkinsonian Patients with Heart Disease”, Lancet, 1, 932–934.

Jenkins R. B. , Mendelson S. H. , Lamid S. , and Klawans H. (1972): “Levodopa Therapy of Patients with Parkinsonism and Heart Disease”, Brit. Med. J., 3, 512–514.

Liu P. L. , Krenis L. J. , and Ngai S. H. (1971): “The Effect of Levodopa on the Norepinephrine Stores in Rat Heart”, Anesthesiology, 34, 4–8.

Parks L. C. , Watanabe A. M. , and Kopin I. J. (1970): “Prevention or Reversal of Levodopa-induced Cardiac Arrhythmias by Decarboxylase Inhibitors”, Lancet, 2, 1014–1015.

Whitsett T. L. , and Goldberg L. I. (1972): “Effects of Levodopa on Systolic Preejection Period, Blood Pressure and Heart Rate during Acute and Chronic Treatment of Parkinson's Disease”, Circulation, 45, 97–106.